Charles River Laboratories International
CRL

Charles River Laboratories International (CRL) news

Recent news

Exail Technologies SA: Berenberg cuts target price to EUR 134 from EUR 145

Berenberg Bank has revised its price target for Exail Technologies SA (Euronext Paris: EXA), lowering it to EUR 134 from EUR 145, while maintaining a "Buy" rating on the stock. The adjustment reflects ongoing developments in the company’s strategic and financial landscape, including recent analyst…

AInvest Wire · 3d ago

Charles River, Autolomous launch Apollo orchestrate platform

On October 6, 2026, Charles River Laboratories and Autolomous announced the launch of an Apollo orchestrate platform, a collaborative initiative aimed at advancing autonomous vehicle technology through integrated software and hardware solutions. The platform builds on the foundational work of…

AInvest Wire · Oct 6, 2026

Charles River Laboratories International - Co and Autolomous launch Apollo orchestrate within Apollo platform

AInvest Wire · Oct 6, 2026

Charles River Laboratories International, Inc.: UBS raises to buy from neutral

On September 30, 2026, UBS analyst Dan Leonard upgraded Charles River Laboratories International, Inc. (NYSE: CRL) to a "Buy" rating from "Neutral," according to recent analyst updates . This move reflects a more positive outlook on the company’s prospects, potentially influenced by its role in the…

AInvest Wire · Sep 30, 2026

Charles River Laboratories International, Inc.: Jefferies raises target price to $340 from $305

Jefferies has revised its price target for Charles River Laboratories International, Inc. (CRL) to $340 from $305, reflecting an increased outlook for the company’s stock performance[1]. The adjustment follows an analysis of the firm’s recent financial results and market positioning. Charles River…

AInvest Wire · Sep 28, 2026

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.